antibodies anticd9 (Danaher Inc)
Structured Review
Antibodies Anticd9, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 757 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ab267479/anti-NCAM1+antibody/10__4314_slash_tjpr__v22i3__8-46-1-12
Average 99 stars, based on 757 article reviews
Images
Related Articles
other:Article Title: Multiple synchronous primary malignant neoplasms: A case report and literature review Article Snippet: Saline:Article Title: Circulating small extracellular vesicle-derived splicing factor 3b subunit 4 as a non-invasive diagnostic biomarker of early hepatocellular carcinoma Article Snippet: Subsequently, 10 μg protein was separated on a 4–20% Mini-PROTEAN TGXTM gel (Bio-Rad Laboratories, Hercules, CA, USA) and transferred onto polyvinylidene difluoride membranes (Amersham; GE Healthcare, Munich, Germany). .. The membranes were blocked using 5% non-fat milk in Tris-Buffer Saline (TBS) and 0.1% Tween-20 and immunoblotted utilizing the following primary antibodies: mouse anti-CD63 (1:1000, ab134045; Abcam, Cambridge, MA, USA), mouse anti-CD81 (1:250, 10630D; Invitrogen, Carlsbad, CA, USA), Western Blot:Article Title: Neuronal MHC-I complex is destabilized by amyloid-β and its implications in Alzheimer’s disease Article Snippet: The blots were incubated with primary antibodies overnight at 4 °C, washed three times in PBS-T buffer, and incubated with horseradish peroxidase-conjugated secondary antibodies for 1 h. The immunoblots were visualized using ECL reagents (Thermo Fisher Scientific Inc.). .. The primary antibodies used in the western blotting analyses were anti-human MHC-I (NBP2-66946, Novus Biologicals, LLC, Littleton, CO, USA); Immunopeptidomics:Article Title: Neuronal MHC-I complex is destabilized by amyloid-β and its implications in Alzheimer’s disease Article Snippet: The blots were incubated with primary antibodies overnight at 4 °C, washed three times in PBS-T buffer, and incubated with horseradish peroxidase-conjugated secondary antibodies for 1 h. The immunoblots were visualized using ECL reagents (Thermo Fisher Scientific Inc.). .. The primary antibodies used in the western blotting analyses were anti-human MHC-I (NBP2-66946, Novus Biologicals, LLC, Littleton, CO, USA); Article Title: Neuronal MHC-I complex is destabilized by amyloid-β and its implications in Alzheimer’s disease Article Snippet: .. To assess the co-localization of MHC-I and NCAM1 or MHC-I and β 2 M on primary neurons in the presence or absence of Aβ oligomer treatment, the cells were fixed and permeabilized with PBS containing 0.5% Triton X-100 for 10 min and incubated with blocking buffer (10% NGS, 5% bovine serum albumin [BSA], and 0.5% Tween 20 in PBS) for 1 h. The cells were subsequently incubated with primary anti-mouse MHC-I(B22-249.R1, Thermo Fisher Scientific Inc), anti-NCAM1(Proteintech) and Bicinchoninic Acid Protein Assay:Article Title: Lipid metabolism of plasma-derived small extracellular vesicles in COVID-19 convalescent patients Article Snippet: .. Protein concentrations were detected with BCA Protein Assay according to the manufacturer’s protocols. Incubation:Article Title: Neuronal MHC-I complex is destabilized by amyloid-β and its implications in Alzheimer’s disease Article Snippet: .. To assess the co-localization of MHC-I and NCAM1 or MHC-I and β 2 M on primary neurons in the presence or absence of Aβ oligomer treatment, the cells were fixed and permeabilized with PBS containing 0.5% Triton X-100 for 10 min and incubated with blocking buffer (10% NGS, 5% bovine serum albumin [BSA], and 0.5% Tween 20 in PBS) for 1 h. The cells were subsequently incubated with primary anti-mouse MHC-I(B22-249.R1, Thermo Fisher Scientific Inc), anti-NCAM1(Proteintech) and Blocking Assay:Article Title: Neuronal MHC-I complex is destabilized by amyloid-β and its implications in Alzheimer’s disease Article Snippet: .. To assess the co-localization of MHC-I and NCAM1 or MHC-I and β 2 M on primary neurons in the presence or absence of Aβ oligomer treatment, the cells were fixed and permeabilized with PBS containing 0.5% Triton X-100 for 10 min and incubated with blocking buffer (10% NGS, 5% bovine serum albumin [BSA], and 0.5% Tween 20 in PBS) for 1 h. The cells were subsequently incubated with primary anti-mouse MHC-I(B22-249.R1, Thermo Fisher Scientific Inc), anti-NCAM1(Proteintech) and Next-Generation Sequencing:Article Title: Neuronal MHC-I complex is destabilized by amyloid-β and its implications in Alzheimer’s disease Article Snippet: .. To assess the co-localization of MHC-I and NCAM1 or MHC-I and β 2 M on primary neurons in the presence or absence of Aβ oligomer treatment, the cells were fixed and permeabilized with PBS containing 0.5% Triton X-100 for 10 min and incubated with blocking buffer (10% NGS, 5% bovine serum albumin [BSA], and 0.5% Tween 20 in PBS) for 1 h. The cells were subsequently incubated with primary anti-mouse MHC-I(B22-249.R1, Thermo Fisher Scientific Inc), anti-NCAM1(Proteintech) and |

